We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > cisplatin

News List

FDA Approves Pembrolizumab for Esophageal or GEJ Carcinoma americanpharmaceuticalreview
March 26, 2021
The U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck Sharp & Dohme Corp.) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or ...
Senhwa Biosciences Presents Positive Cholangiocarcinoma Data prnasia
January 18, 2021
Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announces that promising clinical data from their global phase 1b/2 trial, evaluating ...
NIH study finds clues about why common cancer drug causes hearing loss biospectrumasia
December 22, 2017
Researchers find target to protect hearing during chemotherapy treatment